Related Experiment Videos
Effect of prenatal drug administration on maternal and neonatal platelet aggregation and PF4 release
Insights
Prenatal drug exposure affects platelet function in newborns and mothers. Infants exposed to certain drugs in utero show impaired platelet aggregation and release, indicating potential risks.
Area of Science:
- Neonatal physiology
- Pharmacology
- Hematology
Background:
- Platelet function is crucial for hemostasis.
- Prenatal drug exposure can impact fetal development.
- Platelet antiheparin activity, such as platelet factor 4 (PF4), plays a role in coagulation.
Purpose of the Study:
- To investigate the effects of prenatal drug exposure on platelet function in newborns and their mothers.
- To compare platelet release and aggregation responses between exposed and unexposed infants and mothers.
- To determine if prenatal drug exposure differentially affects platelet responses to various agonists.
Main Methods:
- Assessing platelet antiheparin activity (PF4 release) induced by collagen and l-epinephrine.
- Evaluating platelet aggregation responses to adenosine diphosphate (ADP) and l-epinephrine.
- Comparing responses in infants of mothers with and without antenatal drug exposure.
- Analyzing platelet function in washed platelets resuspended in adult plasma.
Main Results:
- PF4 release was normal in infants without antenatal drug exposure.
- PF4 release was decreased in infants of mothers with membrane-stabilizing drug ingestion, more so than in their mothers.
- Platelets from exposed mothers and infants showed a one-wave aggregation response to ADP.
- Mothers showed a two-wave aggregation response to epinephrine, while neonates lacked this response.
- Newborn infants exhibited altered aggregation and PF4 release responses to epinephrine.
Conclusions:
- Prenatal drug exposure impacts platelet release mechanisms in both mothers and infants.
- The effect on epinephrine-induced platelet response is less pronounced in mothers than in their infants.
- Newborn infants' distinct responses suggest platelet aggregation and release can be independent processes.
- These findings highlight potential neonatal risks associated with certain prenatal drug exposures.
Abstract:
Release of platelet antiheparin activity (platelet factor 4, PF4) induced by collagen and l-epinephrine, is normal in newborn infants without antenatal drug exposure. In contrast, PF4 release in platelets of infants of mothers with membrane-stabilizing drug ingestion is decreased to a greater extent than in their respective mothers. Platelet aggregation gives a qualitative indication of response. Platelets of mothers with antenatal drug exposure and those of their infants showed only a one-wave response to adenosine diphosphate, while platelets of these same mothers still showed a two-wave aggregation response to l-epinephrine. In contrast, platelets of all neonates lacked epinephrine-induced aggregation response, even when washed and resuspended in adult plasma. Our studies show that prenatal drugs have an effect on the platelet release mechanism in both mothers and their exposed infants; but the effect on the epinephrine-induced platelet response is less in mothers. Newborn infants have different aggregation and platelet release response to epinephrine which suggests that platelet aggregation and the release reaction can occur independently of each other.